Mathematical model helps identify determinants of persistent MRSA bacteremia

Mathematical modeling suggests that the rate at which a patient’s immune system clears slow-growing variants of methicillin-resistant Staphylococcus aureus (MRSA) bacteria is a key determinant of whether antibiotics can cure the infection. Tsuyoshi Mikkaichi and Alexander Hoffmann of the University of California, Los Angeles, and the MRSA Systems Immunobiology Group present this work in PLOS Computational Biology.

Mathematical model helps identify determinants of persistent MRSA bacteremia
Credit: Mikkaichi et al.

MRSA infection can lead to a life-threatening condition known as persistent bacteremia, in which the bacteria are persistently present in the bloodstream. Researchers have proposed that when MRSA infects a person, it exists in two forms: normal bacteria and slow-growing variants that are less susceptible to antibiotics. It has been hypothesized that the rate at which normal bacteria switch to slow-growing variants influences whether an infection persists or can be cured.

To explore this question, Mikkaichi and colleagues constructed a mathematical model that simulates the dynamics of both normal and slow-growing bacterial populations during typical antibiotic treatments. The model effectively serves as a diverse group of virtual patients, some of whom are cured and others not, enabling the researchers to make precise predictions of why antibiotics fail for some.

The virtual analysis suggests that the rate at which a patient’s immune system clears slow-growing variants—not the rate at which they are produced—is a key determinant of whether drug treatment fails or succeeds. “Based on these findings, a drug that specifically kills the slow-growing variant may be the most effective treatment for persistent bacteremia,” Mikkaichi says.

The next step for this work is to improve understanding of interactions between slow-growing MRSA variants with the immune system, and why the immune system may be ineffective in killing these bacteria in patients with persistent infections.

These slow-growing variants may be hiding from the immune system by entering the patient’s tissue or immune cells and growing inside them.”  

Tsuyoshi Mikkaichi, University of California, Los Angeles

Principal Investigator Alexander Hoffmann adds:

Training the immune system to recognize MRSA hiding in host cells could be an effective treatment strategy.”

Source:
Journal reference:

Mikkaichi, T. et al. (2019) Identifying determinants of persistent MRSA bacteremia using mathematical modeling. PLOS Computational Biology. doi.org/10.1371/journal.pcbi.1007087.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    PLOS ONE. (2019, July 12). Mathematical model helps identify determinants of persistent MRSA bacteremia. News-Medical. Retrieved on April 16, 2024 from https://www.news-medical.net/news/20190712/Mathematical-model-helps-identify-determinants-of-persistent-MRSA-bacteremia.aspx.

  • MLA

    PLOS ONE. "Mathematical model helps identify determinants of persistent MRSA bacteremia". News-Medical. 16 April 2024. <https://www.news-medical.net/news/20190712/Mathematical-model-helps-identify-determinants-of-persistent-MRSA-bacteremia.aspx>.

  • Chicago

    PLOS ONE. "Mathematical model helps identify determinants of persistent MRSA bacteremia". News-Medical. https://www.news-medical.net/news/20190712/Mathematical-model-helps-identify-determinants-of-persistent-MRSA-bacteremia.aspx. (accessed April 16, 2024).

  • Harvard

    PLOS ONE. 2019. Mathematical model helps identify determinants of persistent MRSA bacteremia. News-Medical, viewed 16 April 2024, https://www.news-medical.net/news/20190712/Mathematical-model-helps-identify-determinants-of-persistent-MRSA-bacteremia.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Many food products sold across Europe fail to meet criteria for marketing to children